Literature DB >> 22180245

Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma.

R Dummer1, M Guggenheim, A W Arnold, R Braun, R von Moos.   

Abstract

Melanoma is the most common lethal cutaneous neoplasm. In order to harmonise treatment and follow-up of melanoma patients, guidelines for the management of melanoma in Switzerland were inaugurated in 2001 and revised in 2006. A new classification and recent results in randomised trials necessitated changes concerning staging and modifications of the recommendations of therapy and follow-up.

Entities:  

Mesh：

Year:  2011        PMID： 22180245     DOI： 10.4414/smw.2011.13320

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN： 0036-7672            Impact factor:   2.193


  13 in total

1.  Re-excision within a radius of 2 cm in patients with melanoma of the skin - sufficient for local oncological radicalness.

Authors:  Strahil Asenov Strashilov; Angel Danchev Yordanov; Mariela Borisova Vasileva-Slaveva; Assia Andrianova Konsoulova
Journal:  Arch Med Sci       Date:  2020-07-08       Impact factor: 3.707

Review 2.  Long-term follow-up for melanoma patients: is there any evidence of a benefit?

Authors:  Natasha M Rueth; Kate D Cromwell; Janice N Cormier
Journal:  Surg Oncol Clin N Am       Date:  2015-01-24       Impact factor: 3.495

Review 3.  Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review.

Authors:  Kate D Cromwell; Merrick I Ross; Yan Xing; Jeffrey E Gershenwald; Richard E Royal; Anthony Lucci; Jeffrey E Lee; Janice N Cormier
Journal:  Melanoma Res       Date:  2012-10       Impact factor: 3.599

Review 4.  A Global Review of Melanoma Follow-up Guidelines.

Authors:  Shannon C Trotter; Novie Sroa; Richard R Winkelmann; Thomas Olencki; Mark Bechtel
Journal:  J Clin Aesthet Dermatol       Date:  2013-09

Review 5.  Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence.

Authors:  Amy A Mrazek; Celia Chao
Journal:  Surg Clin North Am       Date:  2014-08-05       Impact factor: 2.741

6.  Melanoma inhibitory activity in Brazilian patients with cutaneous melanoma.

Authors:  Macanori Odashiro; Gunter Hans Filho; Patricia Rusa Pereira; Ana Rita Coimbra Motta Castro; Alcione Cavalheiro Stief; Elenir Rose Jardim Cury Pontes; Alexandre Nakao Odashiro
Journal:  An Bras Dermatol       Date:  2015-06-01       Impact factor: 1.896

Review 7.  Controversies in the diagnosis and treatment of early cutaneous melanoma.

Authors:  O A Orzan; A Șandru; C R Jecan
Journal:  J Med Life       Date:  2015 Apr-Jun

8.  Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.

Authors:  Maresa Altomonte; Anna Di Giacomo; Paola Queirolo; Paolo Ascierto; Francesco Spagnolo; Emilio Bajetta; Luana Calabrò; Riccardo Danielli; Francesco de Rosa; Michela Maur; Vanna Chiarion-Sileni; Pier Ferrucci; Diana Giannarelli; Alessandro Testori; Ruggero Ridolfi; Michele Maio
Journal:  J Exp Clin Cancer Res       Date:  2013-10-25

Review 9.  To what extent are current guidelines for cutaneous melanoma follow up based on scientific evidence?

Authors:  N J Marciano; T L Merlin; T Bessen; J M Street
Journal:  Int J Clin Pract       Date:  2014-02-18       Impact factor: 2.503

Review 10.  Improving outcomes in patients with melanoma: strategies to ensure an early diagnosis.

Authors:  Rachel K Voss; Tessa N Woods; Kate D Cromwell; Kelly C Nelson; Janice N Cormier
Journal:  Patient Relat Outcome Meas       Date:  2015-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.